D Isenberg
Overview
Explore the profile of D Isenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
4209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sobral S, Ramassur K, Apsley E, Isenberg D
Lupus
. 2017 Aug;
27(2):343-344.
PMID: 28767004
No abstract available.
2.
Bakshi J, Rahman A, Isenberg D
Lupus
. 2017 Jun;
27(1):172-173.
PMID: 28650279
No abstract available.
3.
Isenberg D, Sturgess J, Allen E, Aranow C, Askanase A, Sang-Cheol B, et al.
Arthritis Care Res (Hoboken)
. 2017 Apr;
70(1):98-103.
PMID: 28388813
Objective: To determine the level of agreement of disease flare severity (distinguishing severe, moderate, and mild flare and persistent disease activity) in a large paper-patient exercise involving 988 individual cases...
4.
Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz M, Gladman D, Fortin P, et al.
Lupus
. 2016 Oct;
26(3):311-315.
PMID: 27687028
Objective There is a decreased breast cancer risk in systemic lupus erythematosus (SLE) versus the general population. We assessed a large sample of SLE patients, evaluating demographic and clinical characteristics...
5.
Aguiar R, Araujo C, Martins-Coelho G, Isenberg D
Arthritis Care Res (Hoboken)
. 2016 Apr;
69(2):257-262.
PMID: 27110698
Objective: To describe the clinical outcome and safety of rituximab (RTX) treatment in systemic lupus erythematosus (SLE) patients with severe manifestations or whose disease is refractory to standard immunosuppressive therapy,...
6.
Urowitz M, Gladman D, Anderson N, Su J, Romero-Diaz J, Bae S, et al.
Lupus Sci Med
. 2016 Apr;
3(1):e000143.
PMID: 27099765
Objective: To describe the frequency of myocardial infarction (MI) prior to the diagnosis of systemic lupus erythematosus (SLE) and within the first 2 years of follow-up. Methods: The systemic lupus...
7.
Cohen H, Dore C, Clawson S, Hunt B, Isenberg D, Khamashta M, et al.
Lupus
. 2015 May;
24(10):1087-94.
PMID: 25940537
Introduction: The current mainstay of the treatment of thrombotic antiphospholipid syndrome (APS) is long-term anticoagulation with vitamin K antagonists (VKAs) such as warfarin. Non-VKA oral anticoagulants (NOACs), which include rivaroxaban,...
8.
Tung Chen Y, Isenberg D
Lupus Sci Med
. 2014 Nov;
1(1):e000008.
PMID: 25396059
Necrotising fasciitis (NF) is a rare infection of the subcutaneous tissue, known to be rapidly progressive and potentially fatal. Patients with systemic lupus erythematosus (SLE) may be predisposed to this...
9.
Isenberg D, Shoenfeld Y
Immunol Today
. 2014 Oct;
8(9):279-82.
PMID: 25344285
Polyreactive autoantibodies able to bind double-stranded DNA are a characteristic of systemic lucus erytheamtosus. Here, David Isenberg and Yehuda Shoenfeld discuss the likelihood that DNA is the immunogen in this...
10.
Isenberg D, Dudeney C, Williams W
Immunol Today
. 2014 Oct;
7(12):354-5.
PMID: 25291323
No abstract available.